- Home
- WAFD vs DYN Comparison
WAFD vs DYN Comparison
Compare WAFD & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WAFD | DYN |
|---|---|---|
| Founded | 1917 | 1984 |
| Country | United States | United States |
| Employees | 2037 | N/A |
| Industry | Major Banks | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 3.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | WAFD | DYN |
|---|---|---|
| Price | $35.60 | $17.81 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | $35.00 | ★ $37.00 |
| AVG Volume (30 Days) | 646.6K | ★ 1.7M |
| Earning Date | 04-16-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.15 | N/A |
| P/E Ratio | $11.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.31 | $8.25 |
| 52 Week High | $36.02 | $25.00 |
Technical Indicators
Market Signals| Indicator | WAFD | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 69.52 | 44.70 |
| Support Level | $31.67 | $16.47 |
| Resistance Level | $36.02 | $19.65 |
| Average True Range (ATR) | 0.79 | 0.99 |
| MACD | 0.14 | -0.28 |
| Stochastic Oscillator | 89.18 | 12.32 |
Price Performance
Historical ComparisonAbout WAFD WaFd Inc.
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.